查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2164223

生物列印市場：全球市場預測，2026-2032年

Bioprinting Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物列印市場將成長至 38.4 億美元，複合年成長率為 13.07%。

主要市場統計數據
基準年 2025 16.2億美元
預計年份：2026年 18.4億美元
預測年份 2032 38.4億美元
複合年成長率 (%) 13.07%

生物列印技術推動了組織工程和再生醫學的發展。

生物列印是一種利用積層製造技術將細胞、生物材料和生物活性成分排列成可控制3D圖案的技術。其主要意義在於能夠建構組織模型、可移植結構、藥物測試平台和研究工具，這些工具比傳統的2D方法更能精確地反映生物結構。該技術的廣泛應用取決於列印精度、細胞活力、生物材料性能、工藝可重複性、監管證據以及與生物學和臨床工作流程的整合。

從原型演示到可重複的生物製造

該領域正從概念驗證（PoC）結構轉向可重複的、特定應用的流程。技術進步日益與具有可調機械和生物學特性的生物墨水、改進的血管生成策略、多材料層壓、高解析度列印以及增強的列印後成熟度密切相關。標準化測試、檢驗的品管、可互通的軟體和有據可查的製造流程與印表機效能同等重要。這些要求促進了生命科學研究人員、材料專家、工程師、臨床醫生和監管機構之間的合作。

人工智慧增強了設計、製程控制和檢驗。

人工智慧 (AI) 可透過最佳化支架幾何形狀、選擇程式參數、解讀影像資料以及識別列印條件與細胞行為之間的關係來加速生物列印。機器學習系統還可以透過檢測製造過程中的缺陷並根據感測器和影像輸入調整沉積量來輔助封閉回路型監控。當與高品質的實驗資料集、標準化方案、可解釋模型和人工審核相結合時，AI 的累積效應將最大化。資料管治、模型檢驗、網路安全和可追溯性對於 AI 驅動的工作流程仍然至關重要，以確保為受監管的應用提供可靠的資訊。

區域生態系在研究能力、法規和實用化。

北美受益於強大的生物醫學研究能力、先進的臨床網路和活躍的轉化醫學項目，而拉丁美洲則透過與學術機構的合作以及在再生醫學研究領域的重點投入來提升自身能力。歐洲在材料科學和組織工程方面擁有雄厚的專業知識，並具備協調一致的監管和研究框架，但合規要求可能會延長研發進程。中東的生物醫學創新基礎設施和專業研究計畫正在不斷擴展，而非洲則透過大學、醫療機構和國際合作來提升自身能力。亞太地區（包括日本、中國、韓國、印度和澳洲）在先進製造業、電子、生物技術和公共研究機構的支持下，正經歷強勁的發展動能。在所有地區，獲得專業設施、熟練人員、檢驗的生物材料和臨床合作夥伴仍然是推動技術應用的關鍵因素。

經濟與安全夥伴關係塑造合作與能力建構。

儘管東南亞國協的發展程度因醫療基礎設施和監管成熟度的差異而有所不同，但它們都在加強區域內的研究合作和製造能力。金磚國家成員國在生物醫學研究、工業生產和公共醫療衛生領域各具優勢，但它們的合作受到各國優先事項和技術取得考量的影響。歐盟受益於協調的研究機制和監管統一的努力，而七國集團則將成熟的科學生態系統與嚴謹的證據和品質標準結合。海灣合作理事會國家正在投資先進的醫療衛生和創新基礎設施，為專業的生物列印計畫創造了機會。北約成員國被視為技術與安全共同體，有潛力支持軍民兩用技術韌性、供應鏈連續性和先進製造業合作，儘管生物列印目前仍主要用於醫療和研究領域。

每個國家的能力都反映了其獨特的研究重點和實用化狀況。

澳洲擁有強大的醫學研究實力以及專業的學術和臨床課程。儘管基礎設施和先進設備的取得存在差異，巴西和墨西哥仍在不斷提升其再生醫學能力。加拿大透過其成熟的生物醫學機構支持跨學科研發。中國正大力發展大規模生物製造、生物材料和研究基礎設施，而印度則在工程、製藥和臨床研究領域建構實力。日本和韓國提供先進的製造技術、機器人技術和生物醫學專業知識。法國、德國、義大利、西班牙和英國擁有廣泛的歐洲研究網路，其研究活動也受到嚴格的品質標準和監管要求的限制。美國仍然是生物醫學創新、臨床研究和商業化的重要中心。俄羅斯擁有相關的科學研究能力，但地緣政治因素和供應鏈限制可能會影響合作和設備取得。

優先考慮檢驗的使用案例、品質系統和跨學科實施。

產業領導者應首先專注於生物列印能夠帶來明確可衡量效益的應用案例，例如個人化患者方案、先進的疾病模型和可重複的研究結構。他們還應儘早確立「品質源於設計 (QbD)」原則，包括生物材料規格、細胞衍生管理、環境監測、列印製程檢驗和列印後測試。與臨床醫生、研究機構和監管機構夥伴關係，有助於在進行大規模投資前明確證據要求。領導者還應建立可互通的資料基礎設施，使用獨立的檢驗資料集評估人工智慧工具，並在安全關鍵決策中保持手動監督。區域製造和供應商策略必須確保無菌原料、專用耗材、設備維護、智慧財產權和持續供應。

調查方法結合了文獻、法規、技術和區域分析。

本執行摘要採用結構化的定性方法，對生物列印技術及其應用領域進行評估。評估框架涵蓋列印技術、生物墨水和生物材料、細胞處理、組織成熟、軟體和人工智慧、研究和臨床應用、生產管理以及監管考慮。研究結果按地區分類：北美、拉丁美洲、歐洲、中東和非洲以及亞太地區，並針對特定的經濟和政治因素以及國家群體檢驗。研究成果整合了現有的科學技術知識，重點在於關於可重複性、生物學性能、轉化研究障礙、基礎設施和人才需求等方面的反覆驗證證據。本摘要未使用任何市場估算、預測、佔有率資料或針對特定公司的聲明。

生物列印技術的進步取決於可靠性、證據和生物學性能。

生物列印正在發展成為一個整合生物材料、活細胞、數位設計、自動化製造、成熟和分析檢驗的綜合平台。其長期貢獻不僅取決於概念驗證，還取決於一致的生物學結果、可擴展的品質系統、具有臨床意義的證據以及負責任的數據利用。那些將技術開發與監管合規計劃、跨學科夥伴關係和穩健的供應鏈相結合的機構，將更有能力推動生物列印從專業研究領域走向醫療和生命科學領域值得信賴的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 生物列印市場：依列印模式分類

  • 體外
    • 生物反應器基地
    • 微流體
  • 體內
    • 微創
    • 開放性手術

第8章：生物列印市場：依技術分類

  • 擠壓
    • 機械的
    • 氣壓
    • 螺線管
  • 噴墨
    • 壓電
    • 熱的
  • 雷射輔助
    • 雷射導引前向轉移
    • 立體光刻技術

第9章：生物列印市場：依材料分類

  • 生物材料
  • 細胞
    • 原代培養細胞
    • 幹細胞
  • 水凝膠
    • 自然的
    • 合成
  • 熱塑性樹脂

第10章：生物列印市場：依應用領域分類

  • 藥物發現
    • 器官晶片
    • 毒性篩檢
  • 器官印刷
    • 心
    • 腎
    • 肝
  • 組織工程
    • 骨
    • 軟骨
    • 皮膚
    • 血管

第11章 生物列印市場：依最終用戶分類

  • 醫院
  • 製藥公司
  • 研究機構
    • 學術機構
    • 合約研究機構

第12章 生物列印市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 生物列印市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 生物印刷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 3D Systems Corporation
  • Advanced Solutions Life Sciences LLC
  • Allevi, Inc
  • Aspect Biosystems Ltd
  • BioBots（now part of Allevi）
  • Bioprinting Solutions Ltd
  • CELLINK AB
  • EnvisionTEC
  • FluidForm Inc
  • Futuristic Ink LLC
  • Inventia Life Science Pty Ltd
  • InVivo Biosystems LLC
  • nScrypt Inc
  • Organovo Holdings, Inc
  • Poietis SAS
  • Readily3D Inc
  • regenHU AG
  • RegenHU Ltd
  • Rokit Healthcare
  • Stratasys Ltd
  • TeVido Biodevices Inc

第17章 主要專家

Product Code: MRR-1F6B55426985

The Bioprinting Market is projected to grow by USD 3.84 billion at a CAGR of 13.07% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.62 billion
Estimated Year [2026] USD 1.84 billion
Forecast Year [2032] USD 3.84 billion
CAGR (%) 13.07%

Bioprinting Advances Tissue Engineering and Regenerative Medicine

Bioprinting applies additive manufacturing to place cells, biomaterials, and bioactive components in controlled three-dimensional patterns. Its principal relevance is the creation of tissue models, implantable constructs, drug-testing platforms, and research tools that more closely reflect biological structure than conventional two-dimensional methods. Adoption depends on print fidelity, cell viability, biomaterial performance, process reproducibility, regulatory evidence, and integration with biology and clinical workflows.

From Prototype Demonstrations to Reproducible Biological Manufacturing

The field is shifting from proof-of-concept structures toward repeatable, application-specific workflows. Progress is increasingly tied to bioinks with tunable mechanical and biological properties, improved vascularization strategies, multi-material deposition, higher-resolution fabrication, and better post-print maturation. Standardized testing, validated quality controls, interoperable software, and documented manufacturing processes are becoming as important as printer performance. These requirements favor collaborations among life-science researchers, materials specialists, engineers, clinicians, and regulators.

Artificial Intelligence Strengthens Design, Process Control, and Validation

Artificial intelligence can accelerate bioprinting by optimizing scaffold geometry, selecting process parameters, interpreting imaging data, and identifying relationships between print conditions and cell behavior. Machine-learning systems may also support closed-loop monitoring by detecting defects during fabrication and adjusting deposition in response to sensor or imaging inputs. The cumulative impact is greatest when AI is paired with high-quality experimental datasets, standardized protocols, explainable models, and human review. Data governance, model validation, cybersecurity, and traceability remain essential before AI-supported workflows can reliably inform regulated applications.

Regional Ecosystems Differ in Research Strength, Regulation, and Translation

North America benefits from substantial biomedical research capacity, advanced clinical networks, and active translational programs, while Latin America is developing capabilities through academic partnerships and targeted regenerative-medicine research. Europe combines strong materials science and tissue-engineering expertise with coordinated regulatory and research frameworks, although compliance requirements can lengthen development pathways. The Middle East is expanding biomedical innovation infrastructure and specialized research programs, and Africa is building capacity through university, healthcare, and international collaborations. Asia-Pacific shows broad momentum across Japan, China, South Korea, India, and Australia, supported by advanced manufacturing, electronics, biotechnology, and public research institutions. Across all regions, access to specialized facilities, skilled personnel, validated biomaterials, and clinical partners remains a decisive adoption factor.

Economic and Security Groupings Shape Collaboration and Capability Building

ASEAN countries are strengthening regional research links and manufacturing capabilities, with development shaped by differences in healthcare infrastructure and regulatory maturity. BRICS members bring varied strengths in biomedical research, industrial production, and public-sector healthcare, while collaboration is influenced by national priorities and technology-access considerations. The European Union benefits from coordinated research mechanisms and harmonization efforts, whereas the G7 combines mature scientific ecosystems with demanding evidence and quality expectations. GCC states are investing in advanced healthcare and innovation infrastructure, creating opportunities for specialized bioprinting programs. NATO members, considered as a technology and security community, may support dual-use resilience, supply-chain continuity, and advanced manufacturing cooperation, although bioprinting remains primarily a health and research application.

Country Capabilities Reflect Distinct Research Priorities and Translation Conditions

Australia combines strong medical research with specialized academic and clinical programs. Brazil and Mexico are expanding regenerative-medicine capabilities amid uneven infrastructure and access to advanced equipment. Canada supports interdisciplinary research and translational development through established biomedical institutions. China is advancing biomanufacturing, biomaterials, and research infrastructure at scale, while India is building capacity across engineering, pharmaceuticals, and clinical research. Japan and South Korea contribute sophisticated manufacturing, robotics, and biomedical expertise. France, Germany, Italy, Spain, and the United Kingdom offer deep European research networks, with activity shaped by rigorous quality and regulatory expectations. The United States remains a major center for biomedical innovation, clinical research, and commercialization. Russia maintains relevant scientific capabilities, though collaboration and access to equipment may be affected by geopolitical and supply-chain constraints.

Prioritize Validated Use Cases, Quality Systems, and Cross-Disciplinary Execution

Industry leaders should begin with use cases where bioprinting provides a clearly measurable advantage, such as patient-specific planning, advanced disease models, or reproducible research constructs. They should establish quality-by-design principles early, including biomaterial specifications, cell-source controls, environmental monitoring, print-process validation, and post-print testing. Partnerships with clinicians, research institutions, and regulators can clarify evidence requirements before major investment. Leaders should also build interoperable data infrastructure, assess AI tools against independent validation datasets, and maintain human oversight for safety-critical decisions. Regional manufacturing and supplier strategies should account for sterile inputs, specialized consumables, equipment servicing, intellectual property, and continuity of access.

Methodology Combines Literature, Regulatory, Technology, and Geographic Analysis

This executive summary uses a structured qualitative review of bioprinting as a technology and application domain. The assessment framework considers printing modalities, bioinks and biomaterials, cell handling, tissue maturation, software and AI, research and clinical applications, manufacturing controls, and regulatory considerations. It organizes findings across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and examines the specified economic, political, and country groupings. Insights are synthesized from established scientific and technical knowledge, with emphasis on recurring evidence regarding reproducibility, biological performance, translational barriers, infrastructure, and workforce requirements. No market estimates, shares, forecasts, or company-specific claims are used.

Bioprinting's Progress Depends on Reliability, Evidence, and Biological Performance

Bioprinting is moving toward integrated platforms that connect biomaterials, living cells, digital design, automated fabrication, maturation, and analytical validation. Its long-term contribution will depend less on demonstrations alone and more on consistent biological outcomes, scalable quality systems, clinically relevant evidence, and responsible data use. Organizations that align technical development with regulatory planning, cross-disciplinary partnerships, and resilient supply chains will be better positioned to translate bioprinting from specialized research into dependable healthcare and life-science applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bioprinting Market, by Printing Mode

  • 7.1. Introduction
  • 7.2. In Vitro
    • 7.2.1. Bioreactor Based
    • 7.2.2. Microfluidic
  • 7.3. In Vivo
    • 7.3.1. Minimally Invasive
    • 7.3.2. Open Surgery

8. Bioprinting Market, by Technology

  • 8.1. Introduction
  • 8.2. Extrusion
    • 8.2.1. Mechanical
    • 8.2.2. Pneumatic
    • 8.2.3. Solenoid
  • 8.3. Inkjet
    • 8.3.1. Piezoelectric
    • 8.3.2. Thermal
  • 8.4. Laser Assisted
    • 8.4.1. Laser Induced Forward Transfer
    • 8.4.2. Stereolithography

9. Bioprinting Market, by Material

  • 9.1. Introduction
  • 9.2. Biomaterial
  • 9.3. Cells
    • 9.3.1. Primary Cells
    • 9.3.2. Stem Cells
  • 9.4. Hydrogel
    • 9.4.1. Natural
    • 9.4.2. Synthetic
  • 9.5. Thermoplastic

10. Bioprinting Market, by Application

  • 10.1. Introduction
  • 10.2. Drug Discovery
    • 10.2.1. Organ On Chip
    • 10.2.2. Toxicity Screening
  • 10.3. Organ Printing
    • 10.3.1. Heart
    • 10.3.2. Kidney
    • 10.3.3. Liver
  • 10.4. Tissue Engineering
    • 10.4.1. Bone
    • 10.4.2. Cartilage
    • 10.4.3. Skin
    • 10.4.4. Vascular

11. Bioprinting Market, by End User

  • 11.1. Introduction
  • 11.2. Hospitals
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes
    • 11.4.1. Academia
    • 11.4.2. Contract Research Organization

12. Bioprinting Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Bioprinting Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Bioprinting Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 3D Systems Corporation
  • 16.2. Advanced Solutions Life Sciences LLC
  • 16.3. Allevi, Inc
  • 16.4. Aspect Biosystems Ltd
  • 16.5. BioBots (now part of Allevi)
  • 16.6. Bioprinting Solutions Ltd
  • 16.7. CELLINK AB
  • 16.8. EnvisionTEC
  • 16.9. FluidForm Inc
  • 16.10. Futuristic Ink LLC
  • 16.11. Inventia Life Science Pty Ltd
  • 16.12. InVivo Biosystems LLC
  • 16.13. nScrypt Inc
  • 16.14. Organovo Holdings, Inc
  • 16.15. Poietis SAS
  • 16.16. Readily3D Inc
  • 16.17. regenHU AG
  • 16.18. RegenHU Ltd
  • 16.19. Rokit Healthcare
  • 16.20. Stratasys Ltd
  • 16.21. TeVido Biodevices Inc

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Bioprinting Market, Years Considered for the Study
  • FIGURE 2. Global Bioprinting Market, Research Design
  • FIGURE 3. Global Bioprinting Market, Research Framework
  • FIGURE 4. Global Bioprinting Market, Data Triangulation
  • FIGURE 5. Global Bioprinting Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Bioprinting Market Size, by Printing Mode, 2025 vs 2032 (%)
  • FIGURE 7. Global Bioprinting Market Size, by Printing Mode, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Bioprinting Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Bioprinting Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Bioprinting Market Size, by Material, 2025 vs 2032 (%)
  • FIGURE 11. Global Bioprinting Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Bioprinting Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Bioprinting Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Bioprinting Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Bioprinting Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Bioprinting Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Bioprinting Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Bioprinting Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Bioprinting Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Bioprinting Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Bioprinting Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Bioprinting Market Segmentation & Coverage
  • TABLE 2. Global Bioprinting Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 4. Global In Vitro Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global In Vitro Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global In Vitro Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Bioreactor Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Bioreactor Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Bioreactor Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Microfluidic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Microfluidic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Microfluidic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Minimally Invasive Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Minimally Invasive Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Minimally Invasive Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Open Surgery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Open Surgery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Open Surgery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 23. Global Extrusion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Extrusion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Extrusion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Mechanical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Mechanical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Mechanical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Pneumatic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Pneumatic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Pneumatic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Solenoid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Solenoid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Solenoid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Inkjet Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Inkjet Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Inkjet Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Piezoelectric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Piezoelectric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Piezoelectric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Thermal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Thermal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Thermal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Laser Assisted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Laser Assisted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Laser Assisted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Laser Induced Forward Transfer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Laser Induced Forward Transfer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Laser Induced Forward Transfer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Stereolithography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Stereolithography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Stereolithography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 54. Global Biomaterial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Biomaterial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Biomaterial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Primary Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Primary Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Primary Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Stem Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Stem Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Stem Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Hydrogel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Hydrogel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Hydrogel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Natural Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Natural Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Natural Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Thermoplastic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Thermoplastic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Thermoplastic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 79. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Organ On Chip Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Organ On Chip Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Organ On Chip Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Toxicity Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Toxicity Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Toxicity Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Organ Printing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Organ Printing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Organ Printing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Heart Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Heart Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Heart Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Kidney Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Kidney Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Kidney Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Liver Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Liver Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Liver Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Tissue Engineering Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Tissue Engineering Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Tissue Engineering Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Bone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Bone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Bone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Cartilage Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Global Cartilage Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 108. Global Cartilage Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 109. Global Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 110. Global Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. Global Skin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 112. Global Vascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Global Vascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. Global Vascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 115. Global Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 118. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 119. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 122. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 124. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 125. Global Academia Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 126. Global Academia Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. Global Academia Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 128. Global Contract Research Organization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 129. Global Contract Research Organization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. Global Contract Research Organization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 131. Global Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 132. Asia-Pacific Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Asia-Pacific Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 134. Asia-Pacific Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 135. Asia-Pacific Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 136. Asia-Pacific Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 137. Asia-Pacific Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 138. Asia-Pacific Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 139. Asia-Pacific Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 140. Asia-Pacific Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 141. Asia-Pacific Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 142. Asia-Pacific Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 143. Asia-Pacific Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 145. Asia-Pacific Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 146. Asia-Pacific Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 147. Asia-Pacific Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. Asia-Pacific Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 149. North America Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 150. North America Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 151. North America Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 152. North America Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 153. North America Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 154. North America Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 155. North America Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 156. North America Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 157. North America Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 158. North America Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 159. North America Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 160. North America Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 161. North America Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 162. North America Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 163. North America Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 164. North America Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. North America Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 166. Latin America Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 167. Latin America Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 168. Latin America Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 169. Latin America Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 170. Latin America Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 171. Latin America Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 172. Latin America Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 173. Latin America Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 174. Latin America Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 175. Latin America Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 176. Latin America Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 177. Latin America Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 178. Latin America Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 179. Latin America Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 180. Latin America Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 181. Latin America Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 182. Latin America Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 183. Europe Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 184. Europe Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 185. Europe Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 186. Europe Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 187. Europe Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 188. Europe Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 189. Europe Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 190. Europe Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 191. Europe Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 192. Europe Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 193. Europe Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 194. Europe Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 195. Europe Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 196. Europe Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 197. Europe Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 198. Europe Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 199. Europe Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 200. Middle East Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 201. Middle East Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 202. Middle East Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 203. Middle East Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 204. Middle East Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 205. Middle East Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 206. Middle East Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 207. Middle East Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 208. Middle East Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 209. Middle East Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 210. Middle East Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 211. Middle East Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 212. Middle East Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 213. Middle East Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 214. Middle East Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 215. Middle East Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. Middle East Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 217. Africa Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 218. Africa Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 219. Africa Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 220. Africa Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 221. Africa Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 222. Africa Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 223. Africa Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 224. Africa Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 225. Africa Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 226. Africa Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 227. Africa Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 228. Africa Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 229. Africa Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 230. Africa Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 231. Africa Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 232. Africa Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Africa Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 234. Global Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 235. ASEAN Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 236. ASEAN Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 237. ASEAN Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 238. ASEAN Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 239. ASEAN Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 240. ASEAN Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 241. ASEAN Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 242. ASEAN Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 243. ASEAN Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 244. ASEAN Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 245. ASEAN Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 246. ASEAN Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 247. ASEAN Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 248. ASEAN Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 249. ASEAN Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 250. ASEAN Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 251. ASEAN Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 252. GCC Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 253. GCC Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 254. GCC Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 255. GCC Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 256. GCC Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 257. GCC Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 258. GCC Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 259. GCC Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 260. GCC Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 261. GCC Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 262. GCC Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 263. GCC Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 264. GCC Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 265. GCC Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 266. GCC Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 267. GCC Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 268. GCC Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 269. European Union Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 270. European Union Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 271. European Union Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 272. European Union Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 273. European Union Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 274. European Union Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 275. European Union Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 276. European Union Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 277. European Union Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 278. European Union Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 279. European Union Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 280. European Union Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. European Union Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 282. European Union Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 283. European Union Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 284. European Union Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 285. European Union Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 286. BRICS Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 287. BRICS Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 288. BRICS Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 289. BRICS Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 290. BRICS Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 291. BRICS Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 292. BRICS Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 293. BRICS Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 294. BRICS Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 295. BRICS Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 296. BRICS Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 297. BRICS Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 298. BRICS Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 299. BRICS Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 300. BRICS Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 301. BRICS Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 302. BRICS Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 303. G7 Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 304. G7 Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 305. G7 Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 306. G7 Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 307. G7 Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 308. G7 Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 309. G7 Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 310. G7 Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 311. G7 Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 312. G7 Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 313. G7 Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 314. G7 Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 315. G7 Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 316. G7 Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 317. G7 Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 318. G7 Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 319. G7 Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 320. NATO Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 321. NATO Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 322. NATO Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 323. NATO Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 324. NATO Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 325. NATO Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 326. NATO Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 327. NATO Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 328. NATO Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 329. NATO Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 330. NATO Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 331. NATO Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 332. NATO Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 333. NATO Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 334. NATO Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 335. NATO Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 336. NATO Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 337. Global Bioprinting Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 338. United States Bioprinting Market Size, 2017-2032 (USD Million)
  • TABLE 339. United States Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 340. United States Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 341. United States Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 342. United States Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 343. United States Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 344. United States Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 345. United States Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 346. United States Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 347. United States Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 348. United States Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 349. United States Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 350. United States Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 351. United States Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 352. United States Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 353. United States Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 354. United States Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 355. Canada Bioprinting Market Size, 2017-2032 (USD Million)
  • TABLE 356. Canada Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 357. Canada Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 358. Canada Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 359. Canada Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 360. Canada Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 361. Canada Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 362. Canada Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 363. Canada Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 364. Canada Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 365. Canada Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 366. Canada Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 367. Canada Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 368. Canada Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 369. Canada Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 370. Canada Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 371. Canada Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 372. Mexico Bioprinting Market Size, 2017-2032 (USD Million)
  • TABLE 373. Mexico Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 374. Mexico Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 375. Mexico Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 376. Mexico Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 377. Mexico Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 378. Mexico Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 379. Mexico Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 380. Mexico Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 381. Mexico Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 382. Mexico Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 383. Mexico Bioprinting Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 384. Mexico Bioprinting Market Size, by Drug Discovery, 2017-2032 (USD Million)
  • TABLE 385. Mexico Bioprinting Market Size, by Organ Printing, 2017-2032 (USD Million)
  • TABLE 386. Mexico Bioprinting Market Size, by Tissue Engineering, 2017-2032 (USD Million)
  • TABLE 387. Mexico Bioprinting Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 388. Mexico Bioprinting Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 389. Brazil Bioprinting Market Size, 2017-2032 (USD Million)
  • TABLE 390. Brazil Bioprinting Market Size, by Printing Mode, 2017-2032 (USD Million)
  • TABLE 391. Brazil Bioprinting Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 392. Brazil Bioprinting Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 393. Brazil Bioprinting Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 394. Brazil Bioprinting Market Size, by Extrusion, 2017-2032 (USD Million)
  • TABLE 395. Brazil Bioprinting Market Size, by Inkjet, 2017-2032 (USD Million)
  • TABLE 396. Brazil Bioprinting Market Size, by Laser Assisted, 2017-2032 (USD Million)
  • TABLE 397. Brazil Bioprinting Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 398. Brazil Bioprinting Market Size, by Cells, 2017-2032 (USD Million)
  • TABLE 399. Brazil Bioprinting Market Size, by Hydrogel, 2017-2032 (USD Million)
  • TABLE 400. Brazil Bioprinting Market Size, by Application, 20